NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1578536728 M.D.
Verify on CMS → Shelby Terstriep, M.D.
Hematology & Oncology Physician in Fargo, North Carolina.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
428
Medicare Part D claims · 88 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
81%
generic claims · 19% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
83/100
▼ 0 pts below national avg 83.1 · Above neutral
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Shelby Terstriep, M.D. reported a CMS MIPS final score of 83/100 - below the 83.1 national average - and filed 428 Medicare Part D claims in 2023.
- 83/100
- MIPS score · 0 vs avg
- 428
- Part D claims, 2023
- 81%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Shelby Terstriep, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
83 39th percentile higher than 39% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Shelby Terstriep, M.D. sits
This provider among hematology & oncology physician peers
Across the 4,233 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Shelby Terstriep, M.D. writes more Part D claims than 32% of them and scores higher on MIPS quality than 40% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Shelby Terstriep, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Shelby Terstriep, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Shelby Terstriep, M.D.?
Near national averagePrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
428 49% vs specialty avg
MIPS final score
83/100 0.1 pts vs avg
Specialty distribution in North Carolina
How Hematology & Oncology Physician compares to other specialties among North Carolina providers
Medicare quality performance, MIPS
Shelby Terstriep, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 83/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Hematology & Oncology Physician) - 83/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Shelby Terstriep, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 820 4 STREET NORTH, Fargo, NC, 58122, with a listed phone of (701) 234-2397. NPI 1578536728 was issued on 02/08/2006.
Medicare Part D records for calendar year 2023 show 428 prescription claims written by this provider, covering 88 Medicare beneficiaries and totaling roughly $529K in drug spend, split 19% brand-name and 81% generic by claim count, with an opioid prescribing rate of 4.4%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 83/100 for the 2023 performance year (Quality 87.1, Cost 57.1), compared with the national average of 83.1.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,232 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1578536728 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 02/08/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
82.9973
Final Score
Avg: 83.1
87.0681
Quality
57.0897
Cost
99
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Shelby Terstriep, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Sanford Medical Center Fargo
Perham, MN
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
Shelby Terstriep, M.D. - brand share 19.0%
Hematology & Oncology Physician average
19% brand-name claims vs 81% generic, on 428 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
428
Total Claims
$529K
Total Drug Cost
88
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 844
- Total Day Supply
- 24,339
- Brand vs Generic
- 19% brand / 81% generic
- Brand Drug Cost
- $518K
- Generic Drug Cost
- $11K
- Opioid Claims
- 19 (4.4% rate)
- Antibiotic Claims
- 13
Patient Demographics
- Average Patient Age
- 72.0 years
- Avg HCC Risk Score
- 1.45
- Gender Split
- 88% female / 13% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Shelby Terstriep, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Anastrozole
Anastrozole
73 claims
- Tamoxifen Citrate
Tamoxifen Citrate
36 claims
- Levothyroxine Sodium 28
Levothyroxine Sodium
28 claims
- Gabapentin 22
Gabapentin
22 claims
- Metformin Hcl Er 17
Metformin Hcl Er
17 claims
- Lorazepam 16
Lorazepam
16 claims
- Brukinsa 15
Brukinsa
15 claims
- Ozempic 15
Ozempic
15 claims
| Drug | Claims |
|---|---|
| Anastrozole | 73 |
| Tamoxifen Citrate | 36 |
| Levothyroxine Sodium | 28 |
| Gabapentin | 22 |
| Metformin Hcl Er Metformin Hcl | 17 |
| Lorazepam | 16 |
| Brukinsa Zanubrutinib | 15 |
| Ozempic Semaglutide | 15 |
| Hydroxyurea | 13 |
| Eliquis Apixaban | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Hematology & Oncology Physician in NC →
All providers in North Carolina →
Compare specialties →
Hematology & Oncology Physician Overview
How Shelby Terstriep, M.D. fits within the Hematology & Oncology Physician landscape nationally.
11,232
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider
Shelby Terstriep, M.D.'s 428 claims are below the specialty average of 847.
Nearby Hematology & Oncology Physician Providers in North Carolina
Other clinicians with the same primary specialty enrolled in North Carolina, drawn from the same CMS NPPES roster as Terstriep.
Dr. Jorge Abdallah
MD
Greenville, NC
Thomas Aberant
Durham, NC
Dr. Haritha Ackula
MBBS
Kinston, NC
Dr. Soheir Adam
MD
Durham, NC
Dr. Matthew Alberti
DO
Monroe, NC
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the North Carolina medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore North Carolina
Frequently Asked Questions
What is Shelby Terstriep, M.D.'s specialty? ▼
Shelby Terstriep, M.D. specializes in Hematology & Oncology Physician and practices in Fargo, North Carolina. Credentials: M.D..
How much does Shelby Terstriep, M.D. prescribe under Medicare Part D? ▼
In 2023, Shelby Terstriep, M.D. wrote 428 Medicare Part D claims totaling $529K in drug costs for 88 beneficiaries.
What is Shelby Terstriep, M.D.'s Medicare quality score? ▼
Shelby Terstriep, M.D. has a CMS MIPS Final Score of 83/100 (Quality: 87.1, Cost: 57.1). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Shelby Terstriep, M.D. located? ▼
Shelby Terstriep, M.D. is located at 820 4 STREET NORTH, Fargo, NC, 58122. Phone: (701) 234-2397.
What is Shelby Terstriep, M.D.'s NPI number? ▼
Shelby Terstriep, M.D.'s National Provider Identifier (NPI) is 1578536728, issued on 02/08/2006.
Does Shelby Terstriep, M.D. prescribe more brand-name or generic drugs? ▼
Shelby Terstriep, M.D.'s prescribing is 19% brand-name and 81% generic drugs by claim count, with $518K in brand drug costs.
Does Shelby Terstriep, M.D. prescribe opioids? ▼
Yes, Shelby Terstriep, M.D. had 19 opioid claims in 2023 with an opioid prescribing rate of 4.4%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,232 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Shelby Terstriep, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Shelby Terstriep, M.D.'s most frequently prescribed drugs include Anastrozole, Tamoxifen Citrate, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Shelby Terstriep, M.D. accept Medicare? ▼
Shelby Terstriep, M.D. appears in CMS Medicare data with 428 Part D claims and 88 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Shelby Terstriep, M.D.'s credentials? ▼
Shelby Terstriep, M.D.'s NPI is 1578536728 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.